Skip to main content

Table 2 Clinical and pathologic response to TPF induction chemotherapy according to Annexin A1 expression

From: Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade

  Annexin A1 expression Chi-square
Low High test P value
Clinical response 32 50 0.300
Clinical non-response 5 14
Favorable pathologic response 7 20 0.177
Unfavorable pathologic response 30 44